The Fred Hollows Foundation issues a call to action for International Women's Day

News
Article

The Australia-based organisation is partnering with the UN Friends of Vision group for an event on 11 March

An illustration shows women and girls representing different nationalities and ethnicities. Image credit: ©DisignUA – stock.adobe.com

The event will include UN Friends of Vision leadership and Her Royal Highness the Duchess of Edinburgh GCVO. Image credit: ©DisignUA – stock.adobe.com

The Fred Hollows Foundation, an international development organisation which focuses on improving Indigenous Australian eye health, put out a call for immediate global action for International Women's Day (8 March). The foundation called on global leaders to prioritise women’s and girls’ eye health, emphasising ocular care's crucial role in achieving gender equity and sustainable development.

“Eyes are the windows to gender equity,” said Jennifer Gersbeck, executive director of influence and scaling impact at The Fred Hollows Foundation. “Women and girls account for 55% of the world’s blind and vision-impaired population, yet limited access to eye care keeps them trapped in poverty.”

In partnership with the United Nations Friends of Vision, The Fred Hollows Foundation is co-hosting an International Women’s Day event on Tuesday, 11 March, 2025, at the 69th Commission on the Status of Women in New York. Titled “No Woman Left Behind – Advancing Eye Health Equity for Women and Girls,” the event will include UN Friends of Vision leadership and Her Royal Highness the Duchess of Edinburgh GCVO to discuss global efforts to eliminate trachoma and other gender-based disparities in eye care.

“This is a critical opportunity to push for policies that guarantee all women and girls access to quality eye care. Investing in women’s eye health helps break cycles of poverty, keeps girls in school, and empowers women in the workforce," Gersbeck added. The event marks a key milestone leading up to the 2026 Global Summit on Eye Health, which aims to secure policy commitments for equitable eye care worldwide.

The March 11 event will take place from 12–1:15 PM EST at the Japan Society, located at 333 East 47th Street, in New York City (on the corner of 1st Avenue). To register to attend the event either online or in person, click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
© 2025 MJH Life Sciences

All rights reserved.